← Back to Search

Procedure

Ultrasound Group for Coronavirus (UNITE Trial)

N/A
Waitlist Available
Research Sponsored by Imanuel Lerman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to date of recovery, assessed up to 6 months
Awards & highlights

UNITE Trial Summary

UNITE Study (UCSD-SW) for COVID-19

Eligible Conditions
  • Coronavirus

UNITE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to date of recovery, assessed up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to date of recovery, assessed up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
CRP
IL-1β
IL-6 Change
Secondary outcome measures
Change in time to recovery
Other outcome measures
Change in D-dimer levels
Change in death rate
Change in duration of hypoxemia
+7 more

UNITE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Ultrasound GroupExperimental Treatment1 Intervention
Daily ultrasound application to the spleen of approximately 18 minutes for up to 7 days, in addition to standard clinical care.
Group II: Control GroupActive Control1 Intervention
Control Group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Splenic Ultrasound
2021
N/A
~80

Find a Location

Who is running the clinical trial?

Imanuel LermanLead Sponsor
SecondWave Systems Inc.Industry Sponsor
3 Previous Clinical Trials
87 Total Patients Enrolled
MCDC (Unites States Department of Defense)UNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025